OTTAWA, Sept. 23 /PRNewswire-FirstCall/ - MDS Inc. (TSX:
MDS; NYSE: MDZ), a leading provider of products and services to the
global health science market, today announced it has entered into a
framework agreement with The Open Joint Stock Company "Isotope"
(Isotope), the authorized subsidiary of Rosatom State Corporation,
to explore and define areas of collaboration in the field of
supply, marketing and sale of isotopes produced in Russia.
Conference Call
The Company will host an analyst conference call on Monday, September 27, 2010 at 11:00 am ET with Steve
West, Chief Executive Officer to discuss the announcement.
Peter Dans, Senior Vice President and Chief Financial Officer and
Jill Chitra, Senior Vice President,
Strategic Technologies & Regulatory Affairs will accompany Mr.
West on the call.
You may dial 416-340-2216 (Toronto and international) or 1-866-226-1792
(toll free North America) to join
the call. Interested parties may also access the live webcast of
the conference call from the MDS Nordion website at
www.mdsnordion.com. Following the call, a telephone replay will be
available until Wednesday, October 27,
2010 by dialing 416-695-5800 or 1-800-408-3053, using access
code: 6628440 followed by the number sign. An audio archive will be
available on the website at
http://www.mdsnordion.com/investors/webcasts_and_presentations.asp.
About MDS Inc.
MDS Inc. (TSX: MDS; NYSE: MDZ) is a global health science
company that provides market-leading products and services used for
the prevention, diagnosis and treatment of disease. We are a
leading provider of innovative technologies for use in medical
imaging and radiotherapeutics, and sterilization technologies
benefiting the lives of millions of people in more than 65
countries around the world. Our products and services are used
daily by pharmaceutical and biotechnology companies, medical-device
manufacturers, hospitals, clinics and research laboratories. MDS
has more than 600 highly skilled people in five locations. Find out
more at www.mdsnordion.com.
SOURCE MDS Inc.
Copyright . 23 PR Newswire